Monod Bio Receives $1.5M Gates Foundation Grant for TB Diagnostic Development
Seattle startup will use funding to develop urine-based tuberculosis test using engineered NovoBodies technology for low-resource settings.
Latest Articles
Editor's Top Picks
Clinical Labs Navigate What’s Next After FDA’s LDT Rule Reversal
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
New Multiomic Sequencing Platform Maps Genome and Epigenome in Single Assay
The new platform integrates genomic and epigenomic data in a single long-read sequencing assay, providing high-resolution insights into chromatin structure, gene regulation, and disease mechanisms.
Equipment & Supply Spotlight
SmartLabs Partners with Sonrai to Integrate AI Analytics Platform
The exclusive partnership will bring Sonrai Discovery's precision medicine capabilities to SmartLabs' network of managed research centers.
News, Know-How & Standards
Disease Detection & Understanding
Personalis MRD Test Shows Superior Sensitivity in Lung Cancer Trial
The test demonstrated higher baseline sensitivity for ctDNA detection compared to gene mutation-based testing in AstraZeneca's NeoADAURA study.
